In general, these findings reveal the association between TMPRSS2 downregulation with mutant p53 and MYC oncogenic activities in HNSCC patients, and indicate that the immune signature did not add any substantial effect when all other variables contribution was taken into consideration. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.